Parties
Identify each investor and issuer with legal names, entity types, jurisdiction of formation, and authorized signatory details; include organizational exhibits for complex ownership to prevent ambiguity.
Identify each investor and issuer with legal names, entity types, jurisdiction of formation, and authorized signatory details; include organizational exhibits for complex ownership to prevent ambiguity.
Specify instrument type (equity, convertible note, SAFE, or loan), principal amount, valuation or price, closing schedule, and any tranche or milestone conditions tied to funding.
Include mutual representations and warranties covering authority, organization, solvency, compliance, and absence of undisclosed liabilities; attach disclosure schedules where appropriate.
List required approvals, consents, third‑party waivers, and regulatory clearances, including CFIUS or other national security reviews where applicable, that must be satisfied prior to closing.
Describe restrictions on transfer, ROFR/ROFO mechanics, tag/drag rights, and compliance language addressing securities law registration or exemptions and remedies for breach.
Specify governing state law, dispute resolution method (court or arbitration), jurisdiction for enforcement, and how cross‑border enforcement will be handled to reduce uncertainty.
This agreement is commonly used by foreign individuals, foreign corporations, and U.S. issuers accepting cross‑border capital.
Private equity, venture capital, and real estate sponsors routinely use these agreements to document cross‑border funding and compliance obligations efficiently.
An individual or entity domiciled outside the United States providing capital under the agreement. They must supply accurate tax forms (W-8BEN or W-8BEN-E), comply with sanctions screening and KYC, and may bear tax withholding responsibilities on U.S.-source income.
The U.S. company receiving investment capital; responsible for documenting investor credentials, collecting tax and KYC paperwork, performing required compliance checks, and ensuring the agreement aligns with securities and corporate law.
| Workflow Field and Configuration Details | Setting name | Recommended value | Notes |
|---|---|
| Preferred Authentication Method for Signers | Email link | SMS code recommended | Strong attribution |
| Signature Placement and Required Fields | Signature field | Required | Auto-fill date |
| Conditional Fields and Validation Rules | Investment amount | Validation numeric | Triggers conditional exhibits |
| Document Retention and Audit Trail | Audit trail | Enabled | Store PDF + metadata |
Core technical and integration requirements for eSigning and storing executed Investment Agreements securely and offline.
Typically 2–4 weeks, can extend by agreement.
Set an explicit closing date and funding mechanics.
Define payment milestones and related covenants.
Allow additional 30–90 days for CFIUS or other reviews.
Effective date triggers retention obligations and schedules.
Optica Ventures used an eSign workflow to handle cross‑border subscription agreements for multiple investors with varying document requirements.
Xerox integrated eSignature with NetSuite to automate signature collection on investment and vendor agreements across multiple jurisdictions.
Parties agree principal terms and timeline.
Legal, financial, and compliance reviews completed.
Allow 30–90 days for reviews like CFIUS.
Execute documents, transfer funds, and issue securities.